Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026)
Accuray (ARAY) reported Liabilities and Shareholders Equity of $447.6 million for Q1 2026, up 137.41% on a YoY basis from $188.5 million in Q1 2025, and up 139.68% quarter-over-quarter from $186.7 million in Q4 2025.
Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Accuray has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $447.6 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 137.41% year-over-year to $447.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 141.99% YoY), and the FY2025 full-year result was $470.2 million, up 229.7% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $447.6 million, up from $186.7 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $470.2 million in Q2 2025, with the low at $90.7 million in Q2 2023.
- Historically, Liabilities and Shareholders Equity has averaged $184.0 million across 5 years, with a median of $121.3 million in 2023.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 1.31% — and 2025, when it jumped 229.7%.
- Accuray's Liabilities and Shareholders Equity stood at $105.4 million in 2022, then gained by 15.12% to $121.3 million in 2023, then surged by 31.08% to $159.0 million in 2024, then rose by 17.44% to $186.7 million in 2025, then jumped by 139.68% to $447.6 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $447.6 million (Q1 2026), $186.7 million (Q4 2025), and $456.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | 447.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447.60 Mn |
| Dec 31, 2025 | 186.75 Mn |
| Sep 30, 2025 | 456.82 Mn |
| Jun 30, 2025 | 470.24 Mn |
| Mar 31, 2025 | 188.54 Mn |
| Dec 31, 2024 | 159.01 Mn |
| Sep 30, 2024 | 155.06 Mn |
| Jun 30, 2024 | 142.63 Mn |
| Mar 31, 2024 | 114.93 Mn |
| Dec 31, 2023 | 121.31 Mn |
| Sep 30, 2023 | 108.08 Mn |
| Jun 30, 2023 | 90.74 Mn |
| Mar 31, 2023 | 104.17 Mn |
| Dec 31, 2022 | 105.37 Mn |
| Sep 30, 2022 | 92.18 Mn |
| Jun 30, 2022 | 91.94 Mn |
| Mar 31, 2022 | 93.48 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 81.93 Mn |
| Jun 30, 2021 | 54.52 Mn |